The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
about
Ethnic differences in the +405 and -460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom.Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in ChinaCirculating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional studyEffect of fosinopril on chemerin and VEGF expression in diabetic nephropathy rats.Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice.Differential systemic gene expression profile in patients with diabetic macular edema: responders versus nonresponders to standard treatment.Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edemaIdentifying Common Genetic Risk Factors of Diabetic Neuropathies.Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness.
P2860
Q32177710-CF898FD4-2C51-4054-9FC8-515B0F49652FQ34370502-C20233BE-9CCE-4B00-B9ED-7CAE2E48B02DQ34466706-F4084581-70FD-4034-8B89-C61097201D1AQ35124660-9E32F4CF-C593-4E69-AAB6-1EEAECA7F975Q36261867-CCB46BBE-92E4-4310-B85B-3F774C278FAAQ37400759-F88047A8-40F4-4C37-A756-46CE94F0158BQ37638770-64BC37DF-6E8E-4C76-B8FC-E95CE09D1318Q38174892-04497C6A-3200-4158-AE18-582502395035Q38527798-BC6D3B3C-D96F-4899-8C8A-FA855782A26BQ42324836-78946165-04BA-41CA-8149-609B4580A8BDQ51283955-2DBD9066-1DE7-4297-9B85-A78F077F9B7D
P2860
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@en
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@nl
type
label
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@en
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@nl
prefLabel
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@en
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@nl
P2093
P1476
The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
@en
P2093
Gabriella Mazzolari
Gemma Tremolada
Gianpaolo Zerbini
Rosangela Lattanzio
P2860
P304
P356
10.2165/00129784-200707060-00002
P577
2007-01-01T00:00:00Z
P6179
1021728303